The board of directors of AstraZeneca Pharma India Limited at its Meeting held on December 14, 2022, approved the Resignation of Mr. Gagandeep Singh Bedi (DIN: 07844333) from the Office of Managing Director of the Company with effect from the closing of business hours on December 31, 2022. Reason for Resignation: Consequent to transfer to a new position within AstraZeneca Group.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6,240 INR | -2.04% |
|
-1.75% | +13.05% |
1st Jan change | Capi. | |
---|---|---|
+13.05% | 1.87B | |
+55.32% | 815B | |
+44.05% | 641B | |
-6.75% | 352B | |
+13.56% | 314B | |
+10.68% | 303B | |
+16.57% | 242B | |
+13.31% | 218B | |
+8.48% | 168B | |
-2.81% | 159B |
- Stock Market
- Equities
- ASTRAZEN Stock
- News AstraZeneca Pharma India Limited
- AstraZeneca Pharma India Limited Announces Resignation of Gagandeep Singh Bedi as Managing Director, Effective December 31, 2022